A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Alizapride
Mefruside
The risk or severity of adverse effects can be increased when Mefruside is combined with Magnesium carbonate.
Alizapride
Meticrane
The risk or severity of adverse effects can be increased when Meticrane is combined with Magnesium carbonate.
Alizapride
Cicletanine
The risk or severity of adverse effects can be increased when Cicletanine is combined with Magnesium carbonate.
Alizapride
Spiradoline
The risk or severity of adverse effects can be increased when Spiradoline is combined with Magnesium carbonate.
Alizapride
Rolofylline
The risk or severity of adverse effects can be increased when Rolofylline is combined with Magnesium carbonate.
Alizapride
Canrenone
The risk or severity of adverse effects can be increased when Canrenone is combined with Magnesium carbonate.
Alizapride
Ertugliflozin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium carbonate.
Alizapride
Isosorbide
The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium carbonate.
Alizapride
Potassium citrate
The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium carbonate.
Alizapride
Canrenoic acid
The risk or severity of adverse effects can be increased when Canrenoic acid is combined with Magnesium carbonate.
Alizapride
Azosemide
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium carbonate.
Alizapride
Indisulam
The risk or severity of adverse effects can be increased when Indisulam is combined with Magnesium carbonate.
Alizapride
Ularitide
The risk or severity of adverse effects can be increased when Ularitide is combined with Magnesium carbonate.
Alizapride
Tienilic acid
The risk or severity of adverse effects can be increased when Tienilic acid is combined with Magnesium carbonate.
Alizapride
Piretanide
The risk or severity of adverse effects can be increased when Piretanide is combined with Magnesium carbonate.
Alizapride
Calcium phosphate dihydrate
Magnesium carbonate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Ferric pyrophosphate citrate
Magnesium carbonate can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Sodium tripolyphosphate
Magnesium carbonate can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Calcium Phosphate
Magnesium carbonate can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Dipotassium phosphate
Magnesium carbonate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3